DGX - Quest Diagnostics inks licensing deal for Alzheimer's testing
2023-10-25 08:10:11 ET
More on Quest Diagnostics
- Quest Diagnostics: Moving Past Covid
- Quest Diagnostics Inc. (DGX) Q3 2023 Earnings Call Transcript
- Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
- Quest Diagnostics Non-GAAP EPS of $2.22 beats by $0.03, revenue of $2.3B beats by $30M
- Quest Diagnostics Q3 2023 Earnings Preview
For further details see:
Quest Diagnostics inks licensing deal for Alzheimer’s testing